ADIPOQ and type 2 diabetes mellitus: Similarly, in individuals with impaired glucose tolerance, lower baseline plasma adiponectin levels predicted progression to T2D (11.3 ± 5.5 vs. 16.7 ± 7.6 μg/mL, p = 0.0017) (32).